CU20100252A7 - Derivados de dibenzotiazepina - Google Patents

Derivados de dibenzotiazepina

Info

Publication number
CU20100252A7
CU20100252A7 CUP2010000252A CU20100252A CU20100252A7 CU 20100252 A7 CU20100252 A7 CU 20100252A7 CU P2010000252 A CUP2010000252 A CU P2010000252A CU 20100252 A CU20100252 A CU 20100252A CU 20100252 A7 CU20100252 A7 CU 20100252A7
Authority
CU
Cuba
Prior art keywords
disorder
dibenzotiazepina
derivatives
formula
schizophrenia
Prior art date
Application number
CUP2010000252A
Other languages
English (en)
Other versions
CU23884B1 (es
Inventor
Dean Brown
James R Damewood
Phil Edwards
James Hulsizer
James Campbell Muir
Jr M Edward Pearson
Ashokkumar Bhikkappa Shenvi
Steven Wesolowski
Dan Widzowski
Michael Wood
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20100252(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CU20100252A7 publication Critical patent/CU20100252A7/es
Publication of CU23884B1 publication Critical patent/CU23884B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Los compuestos de la siguiente fórmula: ESPACIO PARA LA FÓRMULA o una sal farmacéuticamente aceptable de este. Dicho compuesto es útil para el tratamiento del trastorno bipolar, trastorno de ansiedad, trastorno del estado de ánimo o la esquizofrenia, u otro trastorno psicótico.
CU20100252A 2008-06-20 2010-12-20 Derivados de dibenzotiazepina CU23884B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof

Publications (2)

Publication Number Publication Date
CU20100252A7 true CU20100252A7 (es) 2011-11-15
CU23884B1 CU23884B1 (es) 2013-04-19

Family

ID=41431860

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100252A CU23884B1 (es) 2008-06-20 2010-12-20 Derivados de dibenzotiazepina

Country Status (37)

Country Link
US (3) US20110160184A1 (es)
EP (1) EP2307389B1 (es)
JP (2) JP5468068B2 (es)
KR (1) KR20110019781A (es)
CN (1) CN102131791B (es)
AR (1) AR072200A1 (es)
AU (1) AU2009260905B2 (es)
BR (1) BRPI0914231A2 (es)
CA (1) CA2728675A1 (es)
CL (1) CL2010001471A1 (es)
CR (1) CR11860A (es)
CU (1) CU23884B1 (es)
CY (1) CY1113845T1 (es)
DK (1) DK2307389T3 (es)
DO (1) DOP2010000393A (es)
EA (1) EA201001889A1 (es)
EC (1) ECSP10010698A (es)
ES (1) ES2402084T3 (es)
HN (1) HN2010002683A (es)
HR (1) HRP20130234T1 (es)
IL (2) IL210081A (es)
ME (1) ME01516B (es)
MX (1) MX2010014203A (es)
MY (1) MY157518A (es)
NI (1) NI201000224A (es)
NZ (1) NZ590616A (es)
PE (1) PE20110029A1 (es)
PL (1) PL2307389T3 (es)
PT (1) PT2307389E (es)
RS (1) RS52703B (es)
SI (1) SI2307389T1 (es)
SV (1) SV2010003769A (es)
TW (1) TWI488854B (es)
UA (1) UA105903C2 (es)
UY (1) UY31919A (es)
WO (1) WO2009154563A1 (es)
ZA (1) ZA201100488B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110019781A (ko) * 2008-06-20 2011-02-28 아스트라제네카 아베 디벤조티아제핀 유도체 및 그의 용도
CN105830477A (zh) * 2013-08-12 2016-08-03 哥莱菲特软件公司 集成操作系统的域管理
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CN106134230A (zh) 2013-11-21 2016-11-16 哥莱菲特软件公司 用于移动信息设备上的远程内容和配置控制的管理域
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
CN120981447A (zh) * 2023-03-08 2025-11-18 法兰克福大学 Slack激活化合物及其医学用途
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294355A (es)
NL293201A (es)
DE1620703B2 (de) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
CH476753A (de) 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
DE1620712A1 (de) * 1962-05-25 1970-06-04 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo-[b,f][1,4]-thiazepine
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
BE632120A (es) 1963-05-09
US3884920A (en) * 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3683034A (en) * 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3908010A (en) * 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3412193A (en) * 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
US3444169A (en) 1966-01-17 1969-05-13 American Cyanamid Co Process for 11 - aminodibenz(b,f)(1,4)oxazepines and analogous thiazepines
NL6715650A (es) 1966-12-16 1968-06-17
US3852446A (en) * 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569731A5 (es) * 1972-04-04 1975-11-28 Wander Ag Dr A
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
JPH0565257A (ja) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd 多環式化合物及びその用途
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
JP3708962B2 (ja) 1994-08-24 2005-10-19 アストラゼネカ・アクチエボラーグ 治療に有用なスピロ−アザ二環式化合物
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
US6342488B1 (en) * 1998-08-18 2002-01-29 Sepracor, Inc. Phosphonorisperidone and sulforisperidone compositions and methods
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
AU5800400A (en) 1999-07-28 2001-02-19 Oswald Wiss Preparations for reducing oxygen consumption during physical efforts
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
US6630462B2 (en) 2000-11-17 2003-10-07 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
WO2002094794A1 (en) 2001-05-18 2002-11-28 Astrazeneca Ab 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
ES2280538T3 (es) 2001-06-01 2007-09-16 Astrazeneca Ab Nuevo ligando para receptores nicotinicos de acetilcolina utiles en terapia.
NZ530764A (en) * 2001-07-09 2008-07-31 Combinatorx Inc Composition comprising a tricyclic antidepressant and a corticosteroid administered simutaneously or within 14 days for treatment of inflammatory disorders
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
CN100558365C (zh) 2001-09-27 2009-11-11 特拉维夫大学拉莫特有限公司 共轭的精神抑制药及其用途
BR0309342A (pt) 2002-04-18 2005-02-15 Astrazeneca Ab Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
DE60334536D1 (de) 2002-04-18 2010-11-25 Astrazeneca Ab Furylverbindungen
MXPA04010190A (es) 2002-04-18 2005-02-03 Astrazeneca Ab Compuestos heterociclicos.
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
CN1681388A (zh) 2002-09-18 2005-10-12 Fmc有限公司 三环衍生物杀虫剂
JP2006510697A (ja) * 2002-12-20 2006-03-30 ビーエーエスエフ　アクチェンゲゼルシャフト 殺虫性ジベンゾ（ヘテロ）アゼピン誘導体
SG159390A1 (en) * 2003-01-23 2010-03-30 Acadia Pharm Inc Use of n-desmethyclozapine to treat human neuropsychiatric disease
EP1495008A1 (en) 2003-02-22 2005-01-12 Teva Pharmaceutical Industries Limited Synthesis of quetiapine and pharmaceutically acceptable salts thereof
DE10310196A1 (de) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
DE602004012083T2 (de) 2003-04-15 2009-04-23 Astrazeneca Ab Neue Verbindungen, die als Verstärker von Glutamatrezeptoren dienen
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
RU2394030C2 (ru) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
WO2005063254A2 (en) 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
US20060063754A1 (en) * 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
MX2007007220A (es) 2004-12-27 2007-08-20 Astrazeneca Ab Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos.
EP1838325A1 (en) * 2005-01-07 2007-10-03 AstraZeneca AB NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f][1,4]THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS
AU2006231497A1 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
US20100016284A1 (en) 2006-12-20 2010-01-21 Astrazeneca Ab Compounds and uses thereof - 151
WO2008100715A1 (en) 2007-02-09 2008-08-21 Astrazeneca Ab Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
KR20110019781A (ko) * 2008-06-20 2011-02-28 아스트라제네카 아베 디벤조티아제핀 유도체 및 그의 용도

Also Published As

Publication number Publication date
IL229560A0 (en) 2014-01-30
HRP20130234T1 (hr) 2013-04-30
IL229560A (en) 2015-07-30
AR072200A1 (es) 2010-08-11
CY1113845T1 (el) 2016-07-27
TW201002702A (en) 2010-01-16
NI201000224A (es) 2012-03-19
MY157518A (en) 2016-06-15
KR20110019781A (ko) 2011-02-28
IL210081A0 (en) 2011-02-28
EA201001889A1 (ru) 2011-08-30
HN2010002683A (es) 2013-01-15
EP2307389A4 (en) 2012-04-11
IL210081A (en) 2013-12-31
ME01516B (me) 2014-04-20
UY31919A (es) 2010-01-29
WO2009154563A1 (en) 2009-12-23
PE20110029A1 (es) 2011-02-11
CA2728675A1 (en) 2009-12-23
ECSP10010698A (es) 2011-01-31
US20090318415A1 (en) 2009-12-24
PT2307389E (pt) 2013-03-28
EP2307389B1 (en) 2013-01-23
PL2307389T3 (pl) 2013-05-31
US8653257B2 (en) 2014-02-18
RS52703B (sr) 2013-08-30
SI2307389T1 (sl) 2013-04-30
CL2010001471A1 (es) 2011-05-06
NZ590616A (en) 2012-09-28
CU23884B1 (es) 2013-04-19
ZA201100488B (en) 2011-10-26
AU2009260905A1 (en) 2009-12-23
DOP2010000393A (es) 2011-01-31
US20110160184A1 (en) 2011-06-30
CR11860A (es) 2011-02-25
AU2009260905B2 (en) 2012-08-23
US8158618B2 (en) 2012-04-17
UA105903C2 (uk) 2014-07-10
US20120202991A1 (en) 2012-08-09
HK1156308A1 (en) 2012-06-08
MX2010014203A (es) 2011-02-22
BRPI0914231A2 (pt) 2015-11-03
CN102131791B (zh) 2014-12-24
TWI488854B (zh) 2015-06-21
JP2011524898A (ja) 2011-09-08
ES2402084T3 (es) 2013-04-26
SV2010003769A (es) 2011-05-20
JP5468068B2 (ja) 2014-04-09
EP2307389A1 (en) 2011-04-13
JP2014098006A (ja) 2014-05-29
CN102131791A (zh) 2011-07-20
DK2307389T3 (da) 2013-04-02

Similar Documents

Publication Publication Date Title
CU20100252A7 (es) Derivados de dibenzotiazepina
DOP2011000113A (es) Pirazolilaminopiridinas como inhibidores de fak
CY1117165T1 (el) Καινοφανεις τρικυκλικες ενωσεις
DOP2012000151A (es) Nuevos compuestos triciclicos
CU24039B1 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
CO6290763A2 (es) Derivados de benzamidas, carboxamidas y nicotinamidas como moduladores alostericos positivos y sus composiciones
EA200900924A1 (ru) Циклизованные производные как ингибиторы eg-5
CR11803A (es) Pirrolopiridinas como inhibidores de cinasa
CU20110052A7 (es) Compuestos orgánicos
DOP2012000149A (es) Compuestos triciclicos novedosos
ECSP12012293A (es) Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos
ECSP12012103A (es) Inhibidores de virus flaviviridae.
AR083169A1 (es) Compuestos para tratar enfermedades neurodegenerativas
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
CR20120177A (es) Nuevos compuestos de espiropiperidina y el uso farmacéutico del mismo para el tratamiento de diabetes
AR087915A1 (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1
CR20120296A (es) Nuevos compuestos de espiropiperidina
CO6300945A2 (es) Compuestos fenil ftalazin - 1l piperidin - 4 - il benzamida o sales farmaceuticamente aceptables de los mismos, utiles como antagonistas de la trayectoria hedgehoc (hh)
BRPI0821102A2 (pt) Preparação de derivados de di-hidropirrol como intermediários
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
MX385276B (es) Tratamiento para la enfermedad de parkinson
AR081893A1 (es) Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina
AR104331A1 (es) Derivados de tetrazol
UY31824A (es) Nuevos compuestos

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)